As of 13 May 2014, RIVM and Erasmus MC have diagnosed the MERS coronavirus in two Dutch people. The patients are related and were infected during a joint journey to Saudi Arabia.

RIVM contributes to the safe use of nanomaterials through research, alerts and policy consultations, and this work is demonstrated in a short informative film.

RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.

Nanotechnology offers improved options for the diagnosis and treatment of cancer.

Researchers searching for signs of Middle East respiratory syndrome coronavirus (MERS-CoV) in different livestock animals have found antibodies specific to the new virus in dromedary camels.

In a new publication, RIVM indicates scientific challenges in the use of the EU definition for nanomaterial in legislation.

In recent years, an increasing number of applications and products containing or using nanomaterials have become available.